60 Degrees Pharmaceuticals, Inc.
SXTP
$1.63
-$0.08-4.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.41M | 1.37M | 984.50K | 802.30K | 681.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.41M | 1.37M | 984.50K | 802.30K | 681.30K |
| Cost of Revenue | 1.44M | 1.44M | 1.61M | 4.50M | 4.42M |
| Gross Profit | -30.10K | -71.60K | -626.10K | -3.69M | -3.74M |
| SG&A Expenses | 6.28M | 6.41M | 6.12M | 5.64M | 5.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.17M | 9.27M | 8.68M | 11.09M | 10.40M |
| Operating Income | -7.76M | -7.91M | -7.70M | -10.28M | -9.72M |
| Income Before Tax | -7.37M | -7.98M | -7.82M | -10.26M | -7.96M |
| Income Tax Expenses | 100.00 | 1.10K | 1.10K | 0.00 | 0.00 |
| Earnings from Continuing Operations | -7.37 | -7.98 | -7.82 | -10.26 | -7.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.20K | 6.60K | 6.60K | 6.90K | 8.60K |
| Net Income | -7.37M | -7.97M | -7.82M | -10.25M | -7.95M |
| EBIT | -7.76M | -7.91M | -7.70M | -10.28M | -9.72M |
| EBITDA | -7.68M | -7.83M | -7.63M | -10.23M | -9.66M |
| EPS Basic | -15.40 | -23.03 | -39.01 | -118.51 | -104.89 |
| Normalized Basic EPS | -9.01 | -13.51 | -22.98 | -71.42 | -61.37 |
| EPS Diluted | -15.40 | -23.03 | -39.01 | -118.51 | -104.89 |
| Normalized Diluted EPS | -9.01 | -13.51 | -22.98 | -71.42 | -61.37 |
| Average Basic Shares Outstanding | 2.67M | 1.85M | 1.05M | 732.80K | 454.10K |
| Average Diluted Shares Outstanding | 2.67M | 1.85M | 1.05M | 732.80K | 454.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |